Update to the NAPRA Natural Health Products Policy
Ephedrine and pseudoephedrine to be removed from the National Drug Schedules by no later than June 28, 2024.
Update to the NAPRA Natural Health Products Policy Read More »
Ephedrine and pseudoephedrine to be removed from the National Drug Schedules by no later than June 28, 2024.
Update to the NAPRA Natural Health Products Policy Read More »
The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on December 3-4, 2023, were finalized effective January 23, 2024.
Note: This invitation is now closed. The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) which serves to advise NAPRA
The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for March 3-4, 2024 is cancelled. The next meeting of the Committee is scheduled for June 2-3, 2024. The
Cancellation of NDSAC Meeting of March 3-4, 2024 Read More »
Please note that the tentative meeting dates and submission deadlines for the National Drug Scheduling Advisory Committee (NDSAC) in 2024 have been updated. http://napra.ca/meeting-schedule
A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on December 3-4, 2023 with the following interim recommendations made: • Acetaminophen and ibuprofen in oral, fixed-dose combinations,
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for December 3-4, 2023. The primary purpose of the meeting is to consider the following matters: Interested
National Drug Scheduling Advisory Committee Meeting December 3-4, 2023 Read More »
The following are the tentative meeting dates for the National Drug Scheduling Advisory Committee (NDSAC) in 2024. http://napra.ca/meeting-schedule
The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for September 17-18, 2023, is cancelled. The next meeting of the Committee is scheduled for December 3-4, 2023. The deadline to
NDSAC Meeting of September 17-18, 2023 Read More »
The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on March 5, 2023 that: were finalized effective April 25, 2023. Final approval of the interim recommendations was